Self-Efficacy and Attributions about Change in Persons Attempting to Reduce Compulsive Sexual Behavior with Medication vs. Placebo

Sexual Addiction and Compulsivity

Volumn 18, Issue 4, 2011, Pages 232-242

  Muench, Frederick ^a   Blain, Leah ^b   Morgenstern, Jon ^a   Irwin, Thomas ^c  

^a Columbia University College of Physicians and Surgeons New York ^*  (United States)

^b UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^c Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859072091     PISSN: 10720162     EISSN: 15325318     Source Type: Journal    
DOI: 10.1080/10720162.2011.625912     Document Type: Article

References (35)

1. Antonuccio, D. O., Danton, W. G. and DeNelsky, G. Y. 1995. Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 26: 574-585.
2. Babyak, M., Blumenthal, J. A., Herman, S., Khatri, P., Doraiswamy, M., Moore, K. and Krishnan, K. R. 2000. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months. Psychosomatic Medicine, 62: 633-638.
3. Bakker, A., Spinhoven, P., van der Does, A. J. W., van Balkom, A. J. L. M. and van Dyck, R. 2002. Locus of control orientation in panic disorder and the differential effects of treatment. Psychotherapy and Psychosomatics, 71: 85-89.
4. Bandura, A. 1989. Human agency in social cognitive theory. American Psychologist, 44: 1175-1184.
5. Basoglu, M., Marks, I. M., Kilic, C., Brewin, C. R. and Swinson, R. P. 1994. Alprazolam and exposure for panic disorder with agoraphobia attribution of improvement to medication predicts subsequent relapse. British Journal of Psychiatry, 164: 652-659.
6. Biondi, M. and Picardi, A. 2003a. Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia. Psychotherapy and Psychosomatics, 72: 110-111.
7. Biondi, M. and Picardi, A. 2003b. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: A follow-up study. Psychotherapy and Psychosomatics, 72: 34-42.
8. Busner, J. and Targum, S. D. 2007. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry, 4: 28-35.
9. Coleman, E., Gratzer, T., Nesvacil, L. and Raymond, N. C. 2000. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: A retrospective study. Journal of Clinical Psychiatry, 61: 282-284.
10. Fong, T. W., De La Garza, R., II and Newton, T. F. 2005. A case report of topiramate in the treatment of nonparaphilic sexual addiction. Journal of Clinical Psychopharmacology, 25: 512-514.
11. Goodman, W. K., Price, L. H., Rasmussen, S. A. and Mazure, C. 1989. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46: 1006-1011.
12. Grov, C., Parsons, J. T. and Bimbi, D. S. 2010. Sexual compulsivity and sexual risk in gay and bisexual men. Archives of Sexual Behavior, 39: 940-949.
13. Guy, W. 1976. "Clinical global impression". In ECDEU assessment manual for psychopharmacology (revised), 217-221. Rockville, MD: National Institute of Mental Health.
14. Hettema, J., Steele, J. and Miller, W. R. 2005. Motivational interviewing. Annual Review of Clinical Psychology, 1: 91-111.
15. Hevey, D., Smith, M. and McGee, H. M. 1998. Self-efficacy and health behaviour: A review. Irish Journal of Psychology, 19: 248-273.
16. Hollander, E., DeCaria, C. M., Finkell, J. N., Begaz, T., Wong, C. M. and Cartwright, C. 2000. A randomized double-blind Fluvoxamine/placebo crossover trial in pathologic gambling. Biological Psychiatry, 47: 813-817.
17. Kadden, R. M. and Litt, M. D. 2011. The role of self-efficacy in the treatment of substance use disorders. Addictive Behaviors, 36: 1120-1126.
18. Kafka, M. P. and Prentky, R. 1992. Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men. Journal of Clinical Psychiatry, 53: 351-358.
19. Kuzma, J. M. and Black, D. W. 2008. Epidemiology, prevalence, and natural history of compulsive sexual behavior. Psychiatric Clinics of North America, 31: 603-611.
20. Lundahl, B. W., Kunz, C., Brownell, C., Tollefson, D. and Burke, B. L. 2010. A meta-analysis of motivational interviewing: Twenty-five years of empirical studies. Research on Social Work Practice, 20: 137-160. doi: 10.1177/1049731509347850
21. Miller, W. R. and Rollnick, S. 1991. Motivational interviewing: Preparing people to change addictive behavior, New York, NY: Guilford Press.
22. Missildine, W., Feldstein, G., Punzalan, J. C. and Parsons, J. T. 2005. S/he loves me, s/he loves me not: Questioning heterosexist assumptions of gender differences for romantic and sexually motivated behaviors. Sexual Addiction & Compulsivity, 12: 65-74.
23. Modell, J. G., Glaser, F. B., Cyr, L. and Mountz, J. M. 1992. Obsessive and compulsive characteristics of craving for alcohol in alcohol abuse and dependence. Alcoholism: Clinical and Experimental Research, 16: 272-274.
24. Morgenstern, J., Muench, F., O'Leary, A., Wainberg, M. L., Parsons, J. T., Hollander, E. and Blain, L. M. in press. Non-paraphilic compulsive sexual behavior and psychiatric co-morbidities in gay and bisexual men. Journal of Sexual Addiction & Compulsivity,
25. Morin, C. M., Colecchi, C., Stone, J., Sood, R. and Brink, D. 1999. Behavioral and pharmacological therapies for late-life insomnia: A randomized controlled trial. Journal of the American Medical Association, 281: 991-999.
26. Pallanti, S., DeCaria, C. M., Grant, J. E., Urpe, M. and Hollander, E. 2005. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). Journal of Gambling Studies, 21: 431-443.
27. Parsons, J. T., Rosof, E. and Mustanski, B. 2008. Medication adherence mediates the relationship between adherence self-efficacy and biological assessments of HIV health among those with alcohol use disorders. AIDS and Behavior, 12: 95-103.
28. Phillips, K. A., Hollander, E., Rasmussen, S. A. and Aronowitz, B. R. 1997. A severity rating scale for body dysmorphic disorder: Development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale. Psychopharmacology Bulletin, 33: 17-22.
29. Powers, M. B., Smits, J. A. J., Whitley, D., Bystritsky, A. and Telch, M. J. 2008. The effect of attributional processes concerning medication taking on return of fear. Journal of Consulting and Clinical Psychology, 76: 478-490.
30. Raymond, N. C., Grant, J. E., Kim, S. W. and Coleman, E. 2002. Treatment of compulsive sexual behaviour with naltrexone and serotonin reuptake inhibitors: Two case studies. International Clinical Psychopharmacology, 17: 201-205.
31. Schwarzer, R., Fuchs, R., Conner, M. and Norman, P. 1996. "Self-efficacy and health behaviours". In Predicting health behavior: Research and practice with social cognition models., 163-196. Maidenhead, BRK England: Open University Press.
32. Sealy, J. R. 1995. Psychopharmacolgic intervention in addictive sexual behavior. Sexual Addiction & Compulsivity, 2: 257-276.
33. Stein, D. J., Hollander, E., Anthony, D. T. and Schneier, F. R. 1992. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias. Journal of Clinical Psychiatry, 53: 267-271.
34. Suarez, T., O'Leary, A., Morgenstern, J., Allen, A., Hollander, E. and O'Leary, A. 2002. "Selective serotonin reuptake inhibitors as a treatment for sexual compulsivity". In Beyond condoms: Alternative approaches to HIV prevention., 199-220. New York, NY US: Kluwer Academic/Plenum Publishers.
35. Wainberg, M. L., Muench, F., Morgenstern, J., Hollander, E., Irwin, T. W., Parsons, J. T. and O'Leary, A. 2006. A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men. Journal of Clinical Psychiatry, 67: 1968-1973.